Journals / Türkiye Fiziksel Tıp ve Rehabilitasyon Dergisi / 2005 / Cilt: 51 - Sayı: 1

Sclerosing multiple myeloma (report of a case)

Sklerozan multiple myelom (bir olgu nedeniyle)

Pages
33–36
Publication Date
2022-11-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Multiple myeloma is a rare but important pathology that must be considered in differential diagnosis of patients admitting to physical therapy outpatient clinics with nonspecific bone pain or artralgia.We examined a rare, non-secretory type multiple myeloma case that we had detected sclerotic bone lesions besides ordinary lytic lesions, with respect to demonstrative musculoskeletal system involvement

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Myeloma, multiple myeloma or plasmacytoma is a malignant tumour originating from plasma cells that synthesize immunoglobulin in abnormal amount and invade the bone marrow.
📊
Key Findings & Data:Multiple myeloma constitutes 27% of whole bone tumours and with this ratio it is the most common malign tumour of the bone.
💡
Conclusion & Impact:Multiple myeloma is a rare but important pathology that must be considered in differential diagnosis of patients admitting to physical therapy outpatient clinics with nonspecific bone pain or artralgia.We examined a rare, non-secretory type multiple myeloma case that we had detected sclerotic bone lesions besides ordinary lytic lesions, with respect to demonstrative musculoskeletal system involvement
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Myeloma, multiple myeloma or plasmacytoma is a malignant tumour originating from plasma cells that synthesize immunoglobulin in abnormal amount and invade the bone marrow. Multiple myeloma constitutes 27% of whole bone tumours and with this ratio it is the most common malign tumour of the bone. Bone involvements with localized or extensive musculoskeletal pain are characteristic. Multiple myeloma is a rare but important pathology that must be considered in differential diagnosis of patients admitting to physical therapy outpatient clinics with nonspecific bone pain or artralgia.We examined a rare, non-secretory type multiple myeloma case that we had detected sclerotic bone lesions besides ordinary lytic lesions, with respect to demonstrative musculoskeletal system involvement

Özet

Myeloma, multiple myelom veya plazmasitoma anormal miktarda immunoglobülin sentezleyen ve kemik iliğini infiltre eden plazma hücrelerinden kaynaklanan, malign bir tümördür. Multiple myelom tüm kemik tümörlerinin %27’sini oluşturur ve bu oran ile kemiğin en sık görülen malign tümörüdür. Lokalize ya da yaygın iskelet sistemi ağrılarının eşlik ettiği kemik tutulumları karakteristiktir. Multiple myelom, nonspesifik kemik ya da eklem ağrıları ile fizik tedavi polikliniklerine başvuran hastalarda, ayırıcı tanıda düşünülmesi gereken nadir ancak önemli bir patolojidir. Biz de, olağan litik kemik lezyonlarının yanı sıra sklerotik kemik lezyonları tespit ettiğimiz, non-sekretuar tipte nadir görülen bir multiple myelom vakasını, özellikle demonstratif iskelet sistemi tutulumu yönünden inceledik.

🔖

Cite This Article

YILDIRIM, A., KONURALP, N., ALBAYRAK, B., ATAKANLI, K. L., ÖZGÜZEL, H., YÜCEL, S. (2022). Sclerosing multiple myeloma (report of a case). Türkiye Fiziksel Tıp ve Rehabilitasyon Dergisi, Cilt: 51 - Sayı: 1, 33–36. https://ajindex.com/articles/629269

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (9)

  1. Barlogie B, Shaughnessy J. Plasma Cell Myeloma. In: Williams Hematology Sixth Edition. Newyork: Mc Graw-Hill Company, 2001: 1279-87
  2. Yochum TR, Rowe LJ. Tumors and Tumorlike Processes; Essentials of Skeletal Radiology. Baltimore: Williams & Wilkins, 1996: 1004-13
  3. Carnesale PG. Malignant Bone Tumors; Campbell’s Operative Orthopaedics. St.Louis: Mosby-Year Book Inc, 1998: 726-7
  4. Ludwig H, Kupman W, Sinzinger H. Radiography and bone scintigraphy in multiple myeloma: a comparative analysis. Br J Radiol 1982; 55(651): 173-81
  5. Greenspan A. Malignant Bone Tumors; Orthopedic Radiology. Philadelphia: Lippincott Williams & Wilkins, 2000: 697-700
  6. Bataille R, Manolagas SC, Berenson JR. Pathogenesis and management of bone lesions in multiple myeloma. Hematol Oncol Clin North Am 1997; 11: 349-61
  7. Kyle RA. Multiple myeloma: Review of 869 cases. Mayo Clin Proc 1975; 50(1): 29-40
  8. Abdalla IA, Tabbara IA. Nonsecretory multiple myeloma. South Med J 2002; 95(7): 761-4
  9. Preud’Homme JL, Hurez D, Danon F, Brouet JC, et al. Intracytoplasmic and surface-bound immunoglobulins in “nonsecretory” and Bence-Jones myeloma. Clin Exp Immunol 1976; 25(3): 428-36.